Doctor Explains Retatrutide: The Most Powerful GLP-1 Weight Loss Drug Yet
Dr. Alex Tatem — Doctor Explains Retatrutide: The Most Powerful GLP-1 Weight Loss Drug Yet
Channel: Dr. Alex Tatem · Our label: Clinician; paid clinician face of Superpower (disclosed) · Source: youtube.com/watch?v=nJa1N7TFEQk
What this video covers
Over the whole of human history, we have gone from struggling to feed people to struggling to wrestle away Jimmy’s second venty Starbucks sugar cookie frappuccino of the day out of his insulin resistant little fingers. And speaking of bones, you haven’t been able to see yours in about 6 years, so maybe lay off the liquid cement. Fat shaming aside, weight loss can feel close to impossible for a lot of people. Fortunately, we now have incredibly powerful tools in the form of GLP1s that are making weight loss and metabolic health an actual achievable goal.
Summary drawn from this video’s own transcript (banked in our research library, pulled 2026-11-07). Claims below are the speaker’s — attributed, not endorsed. This site publishes no dosing, protocol, or sourcing information.
Key points, in the speaker’s own framing
- Fortunately, we now have incredibly powerful tools in the form of GLP1s that are making weight loss and metabolic health an actual achievable goal.
- So, today we’re diving deep on the hottest and most promising weight loss compound of all time, which is reatride.
- Glucagon-l like peptide is either a 30 or 31 amino acid long peptide made by special cells in the intestine known as introindocrine L cells.
- This brings us to point two in our video today where reatride enters the chat as the world’s first triple agonist GLP-1 drug targeting GLP-1 GIP and the glucagon receptor itself.
- Now there’s no approved dose head-to-head readout yet in obesity, but there is a direct phase three reatride versus trespide trial that is ongoing today.
- Point four for today is safety and side effects.
Read next
Educational information only — not medical advice. Peptides discussed on this page include substances that are not FDA-approved.